Infectious Disease News Current Issue

The following articles appeared in the print edition of Infectious Disease News.

Table of Contents

• Global treatment plays key role in HIV prevention
• Emerging resistance, continuous progress in antifungal drug development Dimitrios Kontoyiannis, MD
• ACIP publishes updated 2016 vaccine recommendations for children, teens
• ACIP publishes updated immunization schedule for adults
• Antibody enzyme immunoassay improves rapid detection of Histoplasma
• CDC updates guidelines to prevent sexual transmission of Zika
• FDA approves two indications for Harvoni in patients with HCV, advanced liver disease
• Health care rates, costs high in HCV/HIV patients who fail treatment
• Most clinicians do not mention that HPV, HBV vaccines reduce cancer
• Nosocomial MERS outbreak shows more ‘intense transmission’ of disease
• Proposed budget increases funding for antibiotic resistance, not HIV
• Senate committee proposes updates to FDA application requirements for reusable devices
• USDA finalizes new food safety standards for poultry
• WHO urges mosquito control strategies; proposes $56 million plan to combat Zika
• Treatment as prevention offers opportunities, challenges Carlos del Rio, MD
• Zika virus: Much more than advertised Thomas M Yuill, PhD; Donald Kaye, MD, MACP
• Cidara receives orphan drug status for antifungal to treat Candida infections
• FDA approves expanded label of Daklinza for additional HCV patients
• Deadly Legionnaires’ disease outbreak in Michigan highlights surveillance issues
• Ability to work increases in cART recipients; hurdles remain
• Antibiotics associated with delirium
• Booster vaccine against HBV not needed, researchers find
• Chlorhexidine before cesarean delivery reduces SSI risk
• Detecting AFP clusters provides early warning on polio outbreaks
• Early antiviral therapy for pregnant women with flu reduces hospital duration
• Few infants born to mothers with HCV in Philadelphia undergo testing
• First autopsy of MERS patient reveals infection’s impact on lungs, other organs
• First confirmed human infection of zoonotic parasite reported in Vietnam
• HBV cases increase among IDUs in Appalachian states
• HCV prevalent among former incarcerated individuals, few treated
• HIV patients with TB face elevated risk for death in Eastern Europe
• IBD treatment increases children’s risk for varicella, herpes zoster hospitalization
• Lung surgery improves treatment success for MDR-TB
• Miltefosine may serve as first-line treatment for leishmaniasis
• Multiple sclerosis drug influences John Cunningham virus antibody levels
• New Borrelia species causes Lyme disease in upper Midwest
• 'Nudges' lower rates of inappropriate antibiotic prescriptions
• Oral solithromycin noninferior to oral moxifloxacin for pneumonia
• S. boulardii probiotic does not reduce antibiotic, C. difficile diarrhea
• Socioeconomic status influences risk for influenza hospitalization
• Testing insufficient to prevent HIV spread in adult film industry
• US blacks infrequently receive consistent HIV care
• Vaccine funding grows to $3.6 billion for low-, middle-income countries
• Xpert TB test may be effective in low-burden settings
• Zika virus present in amniotic fluid
• HIV patients on ART still feel infectious despite low viral loads
• Aspirin does not affect immune activation, endothelial function of HIV patients
• CDC guidelines on STI testing for PrEP patients may miss cases
• Co-trimoxazole fails to reduce mortality among HIV-exposed uninfected infants
• Dapivirine vaginal ring safely reduces HIV infections among women
• Harvoni effective for patients with HIV, acute HCV
• Life expectancy increases in HIV patients; significant gap remains
• Meeting national targets could prevent 185,000 new HIV infections by 2020
• Near-universal HIV screening for males requires eightfold increase in testing
• Nurse-led empirical TB treatment for HIV patients does not reduce death
• HCV, HBV, alcohol use associated with ESLD in patients with HIV
• Strokes, TIA more common among female, black HIV patients
• Tailored counseling approach increases PrEP intake among black MSM
• Truvada negatively influences renal function in PrEP
• Viral suppression gains seen among patients receiving HIV care
• Rapid microbiology testing technology and the role of antimicrobial stewardship programs Jeff Brock, PharmD, MBA, BCIDP